ArticleCyborg and bionic systems (Washington, D.C.)2026
AI-Enabled Wearable Ultrasound for Noninvasive Central Venous Pressure Monitoring.
Article in Cyborg and bionic systems (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Central venous pressure (CVP) is a key indicator of right ventricular preload, but measurement with a central venous catheter (CVC) is invasive, time-consuming, and unsuitable for bedside monitoring. We developed and clinically evaluated an artificial intelligence (AI)-enabled wearable ultrasound device for noninvasive estimation of elevated CVP by imaging the internal jugular vein (IJV) and common carotid artery (CCA) in acute and critical patients. In this prospective multi-center clinical study, 349 patients admitted to intensive care units (ICUs) at 2 tertiary hospitals underwent neck vascular imaging with the wearable ultrasound device, while CVP was measured simultaneously via CVC as the reference standard. The dual-decoder spatiotemporal attention network (DSTA-Net) segmentation model automatically quantified IJV and CCA cross-sectional areas, and the dual-modality multilayer perceptron (DM-MLP) integrated these vascular indices with basic clinical parameters to predict elevated CVP (≥8 mmHg). DSTA-Net showed excellent agreement and strong correlation with expert manual measurements while achieving superior segmentation accuracy compared with the baseline segmentation model. Meanwhile, the proposed DM-MLP improved prediction performance by 4% to 8% over conventional baseline architectures, achieving AUCs of 0.91 (internal test set) and 0.87 (external test set). These findings indicate that an AI-integrated wearable ultrasound device can provide accurate, noninvasive bedside assessment of CVP and may offer a promising alternative to invasive catheters for hemodynamic monitoring in acute and critical care settings.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.